Home / Plaque Psoriasis

Plaque Psoriasis

Guselkumab (Tremfya) Gets CHMP Backing for Plaque Psoriasis


The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the plaque psoriasis drug guselkumab (Tremfya, Janssen-Cilag International NV) for approval. The CHMP supported the use of guselkumab for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy, according to an EMA news …

Read More »